Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.050
0.00 (0.00%)
At close: Oct 29, 2024, 4:00 PM
1.984
-0.066 (-3.22%)
After-hours: Oct 29, 2024, 6:41 PM EDT
Cellectar Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 40.03 | 9.56 | 19.87 | 35.7 | 57.17 | 10.61 | Upgrade
|
| Cash & Short-Term Investments | 40.03 | 9.56 | 19.87 | 35.7 | 57.17 | 10.61 | Upgrade
|
| Cash Growth | 215.64% | -51.85% | -44.36% | -37.54% | 438.55% | -19.92% | Upgrade
|
| Prepaid Expenses | 1.34 | 0.89 | 0.66 | 0.87 | 0.77 | 0.77 | Upgrade
|
| Total Current Assets | 41.37 | 10.45 | 20.53 | 36.57 | 57.94 | 11.39 | Upgrade
|
| Property, Plant & Equipment | 1.51 | 1.59 | 0.98 | 0.55 | 0.64 | 0.78 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Total Assets | 42.91 | 12.08 | 21.59 | 37.2 | 58.66 | 12.25 | Upgrade
|
| Accounts Payable | 7.39 | 9.18 | 2.56 | 1.41 | 1.43 | 1.28 | Upgrade
|
| Accrued Expenses | - | - | 2.92 | 2.44 | 2.01 | 1.39 | Upgrade
|
| Current Portion of Leases | 0.07 | 0.06 | 0.05 | 0.14 | 0.12 | 0.11 | Upgrade
|
| Other Current Liabilities | 8.8 | 3.7 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 16.27 | 12.94 | 5.53 | 3.99 | 3.56 | 2.77 | Upgrade
|
| Long-Term Leases | 0.47 | 0.49 | 0.55 | 0.17 | 0.3 | 0.42 | Upgrade
|
| Total Liabilities | 16.74 | 13.43 | 6.08 | 4.16 | 3.86 | 3.19 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 248.15 | 210.07 | 193.62 | 182.56 | 161.53 | 119.59 | Upgrade
|
| Retained Earnings | -239.06 | -217.48 | -179.5 | -150.9 | -126.78 | -111.68 | Upgrade
|
| Total Common Equity | 9.09 | -7.42 | 14.13 | 31.66 | 34.76 | 7.91 | Upgrade
|
| Shareholders' Equity | 26.17 | -1.36 | 15.51 | 33.05 | 54.79 | 9.06 | Upgrade
|
| Total Liabilities & Equity | 42.91 | 12.08 | 21.59 | 37.2 | 58.66 | 12.25 | Upgrade
|
| Total Debt | 0.55 | 0.55 | 0.6 | 0.3 | 0.42 | 0.53 | Upgrade
|
| Net Cash (Debt) | 39.48 | 9.01 | 19.26 | 35.4 | 56.74 | 10.09 | Upgrade
|
| Net Cash Growth | 226.76% | -53.21% | -45.59% | -37.61% | 462.53% | -23.89% | Upgrade
|
| Net Cash Per Share | 2.36 | 0.74 | 2.73 | 6.38 | 28.64 | 13.14 | Upgrade
|
| Filing Date Shares Outstanding | 35.85 | 32.26 | 9.74 | 6.11 | 5.05 | 0.94 | Upgrade
|
| Total Common Shares Outstanding | 33.16 | 20.74 | 9.39 | 6.11 | 4.54 | 0.94 | Upgrade
|
| Working Capital | 25.1 | -2.48 | 15 | 32.58 | 54.38 | 8.62 | Upgrade
|
| Book Value Per Share | 0.27 | -0.36 | 1.51 | 5.18 | 7.65 | 8.43 | Upgrade
|
| Tangible Book Value | 9.09 | -7.42 | 14.13 | 31.66 | 34.76 | 7.91 | Upgrade
|
| Tangible Book Value Per Share | 0.27 | -0.36 | 1.51 | 5.18 | 7.65 | 8.43 | Upgrade
|
| Machinery | - | 1.66 | 0.8 | 0.58 | 0.45 | 0.43 | Upgrade
|
| Leasehold Improvements | - | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.